Files in This Item:
   
ThumbnailE89740.pdf

View/Open

Title: The clinical guideline programme of the National Institute for Clinical Excellence : a review by the World Health Organization, May 2006 / by Kees de Joncheere ... [et al.]
Authors: De Joncheere, Kees
Klazinga, Niek
Mäkelä, Markukka
Oxman, Andrew D
Hill, Suzanne
World Health Organization. Regional Office for Europe
Issue Date: 2007
Publisher: Copenhagen : WHO Regional Office for Europe
Language: English
Abstract: The National Institute of Clinical Excellence (NICE) is responsible for providing guidance to the National Health Service in England and Wales on the clinical- and cost-effectiveness of medicines and medical technologies. NICE requested WHO to carry out an external review of their Clinical Guidelines programme as part of a broader effort to further develop and strengthen the programme. The WHO team of experts based their report on the review of a number of guidelines and extensive discussions with NICE staff, members of the national collaborating centres, the guideline development groups and other stakeholders during the course of two visits during the spring of 2006. The report contains a series of recommendations on how NICE could further develop the guideline development process. As NICE is internationally a leading agency in guideline development, the recommendations and observations contained in this report will be useful to other countries that are involved in similar efforts
Description: EUR/05/5063284
99 p.
Subject: Technology Assessment, Biomedical
Pharmaceutical Preparations
Cost-Benefit Analysis
Economics, Pharmaceutical
Evaluation Studies
Evidence-Based Medicine
United Kingdom
Europe
Context: standards
metadata.dc.subject.other: Pharmaceuticals and Biologicals
Gov't Doc #: EUR/05/5063284
URI: http://www.who.int/iris/handle/10665/107807
Appears in Collections:Technical documents



Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.